Literature DB >> 24845238

Problems with the medicalization of marijuana.

Samuel T Wilkinson1, Deepak Cyril D'Souza2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24845238      PMCID： PMC6248328          DOI： 10.1001/jama.2014.6175

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  Fungal contamination of tobacco and marijuana.

Authors:  P E Verweij; J J Kerremans; A Voss; J F Meis
Journal:  JAMA       Date:  2000-12-13       Impact factor: 56.272

2.  Physicians and medical marijuana.

Authors:  Herbert D Kleber; Robert L DuPont
Journal:  Am J Psychiatry       Date:  2012-06       Impact factor: 18.112

3.  Persistent cannabis users show neuropsychological decline from childhood to midlife.

Authors:  Madeline H Meier; Avshalom Caspi; Antony Ambler; HonaLee Harrington; Renate Houts; Richard S E Keefe; Kay McDonald; Aimee Ward; Richie Poulton; Terrie E Moffitt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

Review 4.  The cannabis withdrawal syndrome.

Authors:  Alan J Budney; John R Hughes
Journal:  Curr Opin Psychiatry       Date:  2006-05       Impact factor: 4.741

5.  Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.

Authors:  Sagnik Bhattacharyya; Paul D Morrison; Paolo Fusar-Poli; Rocio Martin-Santos; Stefan Borgwardt; Toby Winton-Brown; Chiara Nosarti; Colin M O' Carroll; Marc Seal; Paul Allen; Mitul A Mehta; James M Stone; Nigel Tunstall; Vincent Giampietro; Shitij Kapur; Robin M Murray; Antonio W Zuardi; José A Crippa; Zerrin Atakan; Philip K McGuire
Journal:  Neuropsychopharmacology       Date:  2009-11-18       Impact factor: 7.853

6.  Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers.

Authors:  Ziva D Cooper; Sandra D Comer; Margaret Haney
Journal:  Neuropsychopharmacology       Date:  2013-04-22       Impact factor: 7.853

Review 7.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

8.  Marijuana use and risk of lung cancer: a 40-year cohort study.

Authors:  Russell C Callaghan; Peter Allebeck; Anna Sidorchuk
Journal:  Cancer Causes Control       Date:  2013-07-12       Impact factor: 2.506

9.  Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.

Authors:  F M Leweke; D Piomelli; F Pahlisch; D Muhl; C W Gerth; C Hoyer; J Klosterkötter; M Hellmich; D Koethe
Journal:  Transl Psychiatry       Date:  2012-03-20       Impact factor: 6.222
  9 in total
  18 in total

Review 1.  The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients Through a Written Document.

Authors:  Barth Wilsey; J Hampton Atkinson; Thomas D Marcotte; Igor Grant
Journal:  Clin J Pain       Date:  2015-12       Impact factor: 3.442

2.  Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans.

Authors:  Jose Cortes-Briones; Patrick D Skosnik; Daniel Mathalon; John Cahill; Brian Pittman; Ashley Williams; R Andrew Sewell; Mohini Ranganathan; Brian Roach; Judith Ford; Deepak Cyril D'Souza
Journal:  Neuropsychopharmacology       Date:  2015-04-24       Impact factor: 7.853

3.  Older, Less Regulated Medical Marijuana Programs Have Much Greater Enrollment Rates Than Newer 'Medicalized' Programs.

Authors:  Arthur Robin Williams; Mark Olfson; June H Kim; Silvia S Martins; Herbert D Kleber
Journal:  Health Aff (Millwood)       Date:  2016-03       Impact factor: 6.301

Review 4.  Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data.

Authors:  Michael H Andreae; George M Carter; Naum Shaparin; Kathryn Suslov; Ronald J Ellis; Mark A Ware; Donald I Abrams; Hannah Prasad; Barth Wilsey; Debbie Indyk; Matthew Johnson; Henry S Sacks
Journal:  J Pain       Date:  2015-09-09       Impact factor: 5.820

5.  Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation.

Authors:  Lucile Vincent; Derek Vang; Julia Nguyen; Barbara Benson; Jianxun Lei; Kalpna Gupta
Journal:  Haematologica       Date:  2015-12-24       Impact factor: 9.941

6.  Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with posttraumatic stress disorder.

Authors:  Samuel T Wilkinson; Elina Stefanovics; Robert A Rosenheck
Journal:  J Clin Psychiatry       Date:  2015-09       Impact factor: 4.384

Review 7.  Cannabinoids for pediatric epilepsy? Up in smoke or real science?

Authors:  Francis M Filloux
Journal:  Transl Pediatr       Date:  2015-10

8.  The assessment and management of pain in cirrhosis.

Authors:  Matthew Klinge; Tami Coppler; Jane M Liebschutz; Mohannad Dugum; Ajay Wassan; Andrea DiMartini; Shari Rogal
Journal:  Curr Hepatol Rep       Date:  2018-02-22

9.  Relationships between age at first substance use and persistence of cannabis use and cannabis use disorder.

Authors:  Seán R Millar; Deirdre Mongan; Bobby P Smyth; Ivan J Perry; Brian Galvin
Journal:  BMC Public Health       Date:  2021-05-27       Impact factor: 3.295

10.  Why Young Adults Obtain a Medical Marijuana Card: Associations with Health Symptoms and Heaviness of Use.

Authors:  Justin F Hummer; Rachana Seelam; Eric R Pedersen; Joan S Tucker; David J Klein; Elizabeth J D'Amico
Journal:  Cannabis       Date:  2021-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.